FDA Inspection 1059394 — Egis Pharmaceuticals PLC
The FDA completed an inspection of Egis Pharmaceuticals PLC on Jun 8, 2018 in Budapest. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 8, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Budapest (Hungary)